HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1747103Generated: October 31, 2026
(S)-(+)-N-(Boc)-2-methylpiperidine → HCID 12176154, compound
https://huagongshe.com/reaction/1747103
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | (S)-(+)-N-(Boc)-2-methylpiperidine | HCID 11019870 | — |
| Reactant | Sodium periodate | HCID 23667635 | — |
| Catalyst | Ruthenium dioxide hydrate | HCID 16211523 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | HCID 12176154 | HCID 12176154 | 59% |
Reaction Steps
Ruthenium(IV) oxide hydrate (0.8 g, 0.006 mol) then a solution of N-BOC-6(S)-methyl-piperidine (4.00 g, 0.020 mol) in ethyl acetate (240 ml) were added to a solution of sodium periodate (21.36 g, 0.100 mole) in water (200 ml) and strongly stirred for 24 hours at room temperature under argon atmosphere. After separation the aqueous phase was extracted with ethyl acetate (3×100 ml). The combined organic phases were dried with magnesium sulfate and then treated with activated carbon, giving a colorless solution that was evaporated on a rotavapor at 30° C. The residue (3.98 g) was purified by silicagel (125 g) column chromatography with cyclohexane-ethyl acetate (1-1, v/v), furnishing a product (2.50 g, 59% yield) which according to its 1H-NMR spectrum was pure enough for the next reaction step.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09150558B2 |
|---|
| Source dataset | uspto-grants-2015_10 |
|---|
| ORD ID | ord-a0190b0be5604c1583bdb6e417bf05b1 |
|---|
| Source note | uspto-grants-2015_10 |
|---|